{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-024453","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.940965+00:00","generated_at":"2026-06-28T17:08:36.931441+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ultralife reports Q3 operating loss of $0.8M; revenue down 11% to $21.8M","bullets":["Net loss $0.6M ($0.04/diluted share); adjusted EPS unfavorably impacted by $0.08 from supply chain delays.","Revenue $21.8M, down 10.7% YoY; commercial sales up 5%, government/defense sales down 40%.","Delayed shipments from supply chain bottlenecks adversely impacted revenue by ~$4.1M in Q3.","Backlog increased ~22% sequentially; cash $15.9M, up 49% from year-end 2020; debt reduced to $0.3M.","Battery & Energy revenue down 8% to $20.0M; Communications Systems down 31% to $1.8M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-024453","json":"https://secwatch.observer/filing/0001437749-21-024453.json","markdown":"https://secwatch.observer/filing/0001437749-21-024453.md","text":"https://secwatch.observer/filing/0001437749-21-024453.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774921024453/0001437749-21-024453-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774921024453/ulbi20211027_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:08:36.931441+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}